Hellenic Institute For The Study Of Sepsis

This trial is testing if a drug called anakinra can help people with long COVID who have ongoing breathing problems and signs of an overactive immune system. About 182 participants will be randomly assigned to receive either anakinra or a placebo for 4 to 8 weeks. The main goal i…

This study is testing if giving an antibiotic called clarithromycin early to adults with pneumonia can prevent the infection from worsening into life-threatening sepsis. Doctors will use a specific blood test result to identify which pneumonia patients are at the highest risk for…

This study aims to understand why people who survive serious pneumonia, including from COVID-19, have a higher long-term risk of heart disease and poor fitness. Researchers will follow 650 survivors and healthy volunteers for three years, collecting blood and health data to find …

This study aims to understand how COVID-19 increases the risk of long-term lung, heart, and kidney problems, often called Long COVID. Researchers will observe 345 adults, comparing those who had COVID-19 with those who did not, to track organ health over time. The goal is to gath…